KZR logo

Kezar Life Sciences (KZR)

Profile

Full Name

Kezar Life Sciences, Inc.

Ticker Symbol

KZR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 21, 2018

Indexes

Not included

Website

http://www.kezarlifesciences.com

Employees

55

Key Details

Price

$4.11(-4.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$11.49(+18.16% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.11
KZR price is $4.11

30-Day Relative Volume

1.27
KZR 30-day relative volume is 1.27

Price Performance

Price Today change

-4.86%
KZR price is down -4.86% today

Price YTD change

-38.84%
KZR price is down -38.84% since January 1st

Price 1-year change

-49.26%
KZR price is down -49.26% year-on-year

Price 3-year change

-97.26%
KZR price is down -97.26% over the past 3 years

Price Range

Price All-time high

$329.00
KZR price is currently -98.75% below its historical high of $329.00

Price 3-year low

$0.52
KZR price is currently +690.38% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$30.03M
KZR market capitalization is $30.03 million

Market cap 3-year change

-96.65%
KZR market capitalization is down -96.65% over the past 3 years

Market cap All-time high

$1.04B
KZR market capitalization is currently -97.11% below its historical high of $1.04 billion

Market cap sector rank

31.5%
KZR market capitalization is higher than 31.5% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.35%
KZR shares outstanding is up +0.35% year-on-year

Shares Outstanding 3-Year Change

+22.24%
KZR shares outstanding is up +22.24% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.74
KZR beta is 0.74

200-day SMA

$6.40
KZR price is currently -35.75% below its 200-day simple moving average

50-day SMA

$5.51
KZR price is currently -25.41% below its 50-day simple moving average

RSI

34.68
KZR 14-day relative strength index is 34.68

Volume

1.27
KZR 30-day relative volume is 1.27

ATR

$0.43
KZR average true range is $0.43

10-day Historical Volatility

90.33%
KZR 10-day historical volatility is 90.33%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
KZR annual revenue value is unknown

Revenue Analysts estimate

-
KZR annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
KZR annual revenue 1-year change is unknown

Revenue Sector rank

-
KZR annual revenue is unknown

EPS

EPS

-$11.49
KZR annual earnings per share is -$11.49

EPS Analysts estimate

-$9.30
KZR annual earnings per share is currently +23.55% higher than the consensus analysts' forecast

EPS 1-year change

+18.16%
KZR annual earnings per share is up +18.16% year-on-year

EPS Sector rank

10.59%
KZR annual earnings per share is higher than 10.59% of companies in Healthcare sector

Profit

Gross profit

-
KZR annual gross profit value is unknown

Gross margin

-
KZR annual gross profit margin value is unknown

Operating profit

-$89.14M
KZR annual operating income is -$89.14 million

Operating margin

-
KZR annual operating profit margin value is unknown

Net income

-$83.74M
KZR annual net profit is -$83.74 million

Net margin

-
KZR annual net profit margin value is unknown

Expenses

Total expenses

$89.14M
KZR annual total expenses is $89.14 million

Operating expenses

$89.14M
KZR annual total operating expenses is $89.14 million

Cost of goods sold

-
KZR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$23.39M
KZR annual SGA is $23.39 million

Depreciation and amortization

$1.04M
KZR annual depreciation & amortization is $1.04 million

Interest expense

$1.59M
KZR annual interest expense is $1.59 million

Income tax

-
KZR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$82.14M
KZR annual earnings before interest & taxes is -$82.14 million

EBITDA

-$81.10M
KZR annual EBITDA is -$81.10 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$144.68M
KZR annual total assets is $144.68 million

Non current assets

$7.19M
KZR annual long term assets is $7.19 million

Current assets

$137.49M
KZR annual total current assets is $137.49 million

Cash and cash equivalents

$41.75M
KZR annual cash & cash equivalents is $41.75 million

Accounts receivable

-
KZR annual accounts receivable value is unknown

Inventory

-
KZR annual inventory value is unknown

Liabilities

Total liabilities

$27.77M
KZR annual total liabilities is $27.77 million

Long term liabilities

$7.44M
KZR annual total long term liabilities is $7.44 million

Current liabilities

$20.33M
KZR annual total current liabilities is $20.33 million

Accounts payable

$3.65M
KZR annual accounts payable is $3.65 million

Debt

Total debt

$16.18M
KZR annual total debt is $16.18 million

Total debt 1-year change

-14.54%
KZR annual total debt is down -14.54% year-on-year

Long term debt

$7.44M
KZR annual long term debt is $7.44 million

Short term debt

$8.74M
KZR annual short term debt is $8.74 million

Equity & Capital

Shareholders equity

$116.92M
KZR annual stockholders equity is $116.92 million

Book value

$116.92M
KZR annual book value is $116.92 million

Retained earnings

-$434.50M
KZR annual retained earnings is -$434.50 million

Working capital

$117.16M
KZR annual working capital is $117.16 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$74.21M
KZR annual cash flow from operations is -$74.21 million

Cash from operations 1-year change

+9.1%
KZR annual cash flow from operations is up +9.1% year-on-year

Cash from investing

$80.43M
KZR annual cash flow from investing activities is $80.43 million

Cash from investing 1-year change

+5.76%
KZR annual cash flow from investing activities is up +5.76% year-on-year

Cash from financing

$103.00K
KZR annual cash flow from financing activities is $103.00 thousand

Cash from financing 1-year change

-83.86%
KZR annual cash flow from financing activities is down -83.86% year-on-year

CAPEX

CAPEX

-
KZR annual capital expenditures value is unknown

CAPEX 1-year change

-
KZR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$74.24M
KZR annual free cash flow is -$74.24 million

Free cash flow 1-year change

+11.04%
KZR annual free cash flow is up +11.04% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
KZR annual gross profit margin value is unknown

Operating margin

-
KZR annual operating profit margin value is unknown

Net margin

-
KZR annual net profit margin value is unknown

ROA & ROE

ROA

-57.88%
KZR annual return on assets is -57.88%

ROE

-71.62%
KZR annual return on equity is -71.62%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
KZR price to earnings ratio value is unknown

PE ratio Sector rank

-
KZR price to earnings ratio is unknown

PB Ratio

PB ratio

0.26
KZR price to book ratio is 0.26

PB ratio Sector rank

21.48%
KZR price to book ratio is higher than 21.48% of companies in Healthcare sector

PS Ratio

PS ratio

-
KZR price to sales ratio value is unknown

PS ratio Sector rank

-
KZR price to sales ratio is unknown

Enterprise value

Enterprise value

$4.46M
KZR enterprise value is $4.46 million

Enterprise value Sector rank

18.6%
KZR enterprise value is higher than 18.6% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.05
KZR EV/EBITDA is -0.05

EV/EBITDA Sector rank

63.3%
KZR EV/EBITDA is higher than 63.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.76
KZR annual current ratio is 6.76

Quick ratio

-
KZR annual quick ratio value is unknown

Leverage

Debt to equity

0.14
KZR annual debt to equity ratio is 0.14

Interest coverage ratio

-51.56
KZR annual interest coverage ratio is -51.56

Risk & Stability

Piotroski F-Score

-
KZR piotroski f-score value is unknown

Altman Z-Score

-
KZR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 19, 24 Wells Fargo
Equal-Weight
Dec 2, 24 HC Wainwright & Co.
Neutral
Nov 14, 24 Wells Fargo
Equal-Weight
Oct 18, 24 HC Wainwright & Co.
Neutral
Oct 14, 24 HC Wainwright & Co.
Neutral
Oct 2, 24 HC Wainwright & Co.
Neutral
Aug 14, 24 HC Wainwright & Co.
Buy
Jul 22, 24 HC Wainwright & Co.
Buy
May 10, 24 HC Wainwright & Co.
Buy
Mar 15, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ESLA logo
Estrella Immunopharma (ESLA)
Spectral AI (MDAI)
RBOT logo
Vicarious Surgical (RBOT)
FEMY logo
Femasys (FEMY)
RNXT logo
RenovoRx (RNXT)
CASI logo
CASI Pharmaceuticals (CASI)
LVTX logo
LAVA Therapeutics NV (LVTX)
FGEN logo
FibroGen (FGEN)
INKT logo
MiNK Therapeutics (INKT)
  • What is the ticker symbol for Kezar Life Sciences?
  • Does Kezar Life Sciences pay dividends?
  • What sector is Kezar Life Sciences in?
  • What industry is Kezar Life Sciences in?
  • What country is Kezar Life Sciences based in?
  • When did Kezar Life Sciences go public?
  • Is Kezar Life Sciences in the S&P 500?
  • Is Kezar Life Sciences in the NASDAQ 100?
  • Is Kezar Life Sciences in the Dow Jones?
  • When was Kezar Life Sciences's last earnings report?
  • When does Kezar Life Sciences report earnings?
  • Should I buy Kezar Life Sciences stock now?

What is the ticker symbol for Kezar Life Sciences?

The ticker symbol for Kezar Life Sciences is NASDAQ:KZR

Does Kezar Life Sciences pay dividends?

No, Kezar Life Sciences does not pay dividends

What sector is Kezar Life Sciences in?

Kezar Life Sciences is in the Healthcare sector

What industry is Kezar Life Sciences in?

Kezar Life Sciences is in the Biotechnology industry

What country is Kezar Life Sciences based in?

Kezar Life Sciences is headquartered in United States

When did Kezar Life Sciences go public?

Kezar Life Sciences's initial public offering (IPO) was on June 21, 2018

Is Kezar Life Sciences in the S&P 500?

No, Kezar Life Sciences is not included in the S&P 500 index

Is Kezar Life Sciences in the NASDAQ 100?

No, Kezar Life Sciences is not included in the NASDAQ 100 index

Is Kezar Life Sciences in the Dow Jones?

No, Kezar Life Sciences is not included in the Dow Jones index

When was Kezar Life Sciences's last earnings report?

Kezar Life Sciences's most recent earnings report was on Mar 25, 2025

When does Kezar Life Sciences report earnings?

The next expected earnings date for Kezar Life Sciences is May 9, 2025

Should I buy Kezar Life Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page